{"log_id": 2490901674666876010, "direction": 0, "words_result_num": 50, "words_result": [{"probability": {"variance": 0.019265, "average": 0.903387, "min": 0.512741}, "location": {"width": 194, "top": 180, "height": 22, "left": 734}, "words": "75%起始剂量,无露延迟"}, {"probability": {"variance": 0.050044, "average": 0.849642, "min": 0.395086}, "location": {"width": 121, "top": 194, "height": 20, "left": 204}, "words": "10001501"}, {"probability": {"variance": 0.018539, "average": 0.912286, "min": 0.630316}, "location": {"width": 175, "top": 208, "height": 25, "left": 747}, "words": "起始剂量,无需延迟"}, {"probability": {"variance": 0, "average": 0.967508, "min": 0.967508}, "location": {"width": 40, "top": 247, "height": 21, "left": 454}, "words": "和"}, {"probability": {"variance": 0.022209, "average": 0.910439, "min": 0.52732}, "location": {"width": 317, "top": 234, "height": 29, "left": 704}, "words": "X:延迟直至ANC≥1000瓶小板"}, {"probability": {"variance": 0.032197, "average": 0.846955, "min": 0.45242}, "location": {"width": 235, "top": 266, "height": 21, "left": 712}, "words": "00.00,然后当AN流1000全"}, {"probability": {"variance": 0.045336, "average": 0.7817, "min": 0.414322}, "location": {"width": 222, "top": 293, "height": 23, "left": 705}, "words": "溶疗量为起煌剂的75%"}, {"probability": {"variance": 0.004844, "average": 0.960016, "min": 0.776929}, "location": {"width": 203, "top": 320, "height": 26, "left": 705}, "words": "时治疗量为起始剂量的10"}, {"probability": {"variance": 0.044073, "average": 0.822052, "min": 0.44037}, "location": {"width": 288, "top": 347, "height": 25, "left": 736}, "words": "延遮直至ANC100稚血小振"}, {"probability": {"variance": 0.006688, "average": 0.884132, "min": 0.712297}, "location": {"width": 248, "top": 375, "height": 24, "left": 777}, "words": "然后当ANC100150时"}, {"probability": {"variance": 0.03088, "average": 0.870559, "min": 0.436306}, "location": {"width": 284, "top": 404, "height": 25, "left": 706}, "words": "治疗量为原量的759当ANC"}, {"probability": {"variance": 0.010733, "average": 0.951519, "min": 0.617514}, "location": {"width": 204, "top": 433, "height": 24, "left": 705}, "words": "时治疗量为起始剂量的10"}, {"probability": {"variance": 0.000526, "average": 0.992718, "min": 0.858741}, "location": {"width": 779, "top": 461, "height": 38, "left": 248}, "words": "如果治疗期间进行的非计划评估发现剂量限制性毒性,必须中断这一疗程中卡培他滨的"}, {"probability": {"variance": 0.000333, "average": 0.989908, "min": 0.936139}, "location": {"width": 500, "top": 504, "height": 35, "left": 206}, "words": "给药,在此后的疗程中卡培他滨和顺铂应减量,见表6"}, {"probability": {"variance": 0.001722, "average": 0.980797, "min": 0.776665}, "location": {"width": 701, "top": 539, "height": 40, "left": 269}, "words": "表6.卡培他滨(X)联合顺铂(P)治疗期间出现血液毒性时进行的剂量调整方案"}, {"probability": {"variance": 0.000419, "average": 0.984491, "min": 0.944316}, "location": {"width": 128, "top": 590, "height": 23, "left": 323}, "words": "剂量限制性毒性"}, {"probability": {"variance": 0.010329, "average": 0.946431, "min": 0.672521}, "location": {"width": 197, "top": 584, "height": 24, "left": 707}, "words": "卡培他滨与顺铂剂量调整"}, {"probability": {"variance": 0.000767, "average": 0.980258, "min": 0.90003}, "location": {"width": 236, "top": 626, "height": 26, "left": 224}, "words": "级中性粒细胞减少症超过5天"}, {"probability": {"variance": 0.049203, "average": 0.897052, "min": 0.354994}, "location": {"width": 102, "top": 622, "height": 23, "left": 616}, "words": "75%起始量"}, {"probability": {"variance": 0.002181, "average": 0.964836, "min": 0.877097}, "location": {"width": 96, "top": 651, "height": 21, "left": 621}, "words": "5%起始剂量"}, {"probability": {"variance": 0.021253, "average": 0.91517, "min": 0.599265}, "location": {"width": 127, "top": 684, "height": 23, "left": 224}, "words": "级小板减少症"}, {"probability": {"variance": 0.039506, "average": 0.835886, "min": 0.471813}, "location": {"width": 75, "top": 679, "height": 21, "left": 643}, "words": "a起始剂量"}, {"probability": {"variance": 0.00158, "average": 0.973833, "min": 0.880097}, "location": {"width": 103, "top": 708, "height": 21, "left": 615}, "words": "50%起始剂量"}, {"probability": {"variance": 0.016589, "average": 0.94428, "min": 0.446914}, "location": {"width": 348, "top": 737, "height": 28, "left": 215}, "words": "中性粒细胞减少性发热,中性细胞减少性歟"}, {"probability": {"variance": 0.019076, "average": 0.938297, "min": 0.350153}, "location": {"width": 417, "top": 732, "height": 24, "left": 615}, "words": "中断治疗,除非医师认为血液毒性恢复至0-级后,继"}, {"probability": {"variance": 0.009924, "average": 0.924452, "min": 0.705085}, "location": {"width": 230, "top": 768, "height": 22, "left": 215}, "words": "症,中性粒维胞减少性感染"}, {"probability": {"variance": 0.002154, "average": 0.970896, "min": 0.855038}, "location": {"width": 304, "top": 761, "height": 26, "left": 587}, "words": "续以50%的始剂量治疗,对患者最有利"}, {"probability": {"variance": 0.009454, "average": 0.958916, "min": 0.586622}, "location": {"width": 419, "top": 788, "height": 25, "left": 614}, "words": "中斯治疗,除非医师认为血液毒性恢复至0-1级后,继"}, {"probability": {"variance": 0.002124, "average": 0.970956, "min": 0.823616}, "location": {"width": 306, "top": 817, "height": 29, "left": 586}, "words": "续以50%的始剂量治疗,对患者最有利"}, {"probability": {"variance": 0.00111, "average": 0.984333, "min": 0.885725}, "location": {"width": 190, "top": 856, "height": 26, "left": 223}, "words": "根据NCIC分级标准"}, {"probability": {"variance": 0.000236, "average": 0.986858, "min": 0.944595}, "location": {"width": 338, "top": 891, "height": 35, "left": 218}, "words": "非血液毒性时的剂量调整:卡培他滨"}, {"probability": {"variance": 0.009314, "average": 0.978392, "min": 0.406089}, "location": {"width": 774, "top": 927, "height": 36, "left": 260}, "words": "卡培他滨剂量调整的建议适用于与卡培他滨有关的毒副作用而不是与顺铂或联治疗"}, {"probability": {"variance": 0.00477, "average": 0.985032, "min": 0.563525}, "location": {"width": 823, "top": 965, "height": 39, "left": 217}, "words": "有关的毒副作用。如:神经毒性或耳毒性并不需要减少卡培他滨剂量:如果发生2、3或4"}, {"probability": {"variance": 0.000829, "average": 0.98659, "min": 0.838936}, "location": {"width": 800, "top": 1004, "height": 39, "left": 218}, "words": "级非血液毒性反应,必须马上中断或停止卡培他滨治疗,见表3也可见第一节,注意事项)"}, {"probability": {"variance": 0.000576, "average": 0.992224, "min": 0.872883}, "location": {"width": 816, "top": 1044, "height": 39, "left": 221}, "words": "卡培他滨治疗中断应被算作治疗时间的缺失,缺失的剂量不予补服。应该继续维持原定的治"}, {"probability": {"variance": 0.002288, "average": 0.977022, "min": 0.807246}, "location": {"width": 458, "top": 1087, "height": 34, "left": 218}, "words": "疗方案。如果治疗中计算的肌酐清除率小于30ml/"}, {"probability": {"variance": 0.00067, "average": 0.984503, "min": 0.925167}, "location": {"width": 298, "top": 1084, "height": 29, "left": 723}, "words": "应停止卡培他滨治疗。表7结"}, {"probability": {"variance": 0.001391, "average": 0.985154, "min": 0.851945}, "location": {"width": 438, "top": 1127, "height": 32, "left": 219}, "words": "根据肌酐清除率进行的卡培他滨和顺铂剂量调整"}, {"probability": {"variance": 0.02726, "average": 0.930183, "min": 0.395972}, "location": {"width": 273, "top": 1169, "height": 29, "left": 224}, "words": "非血液毒性的剂量调整:顺"}, {"probability": {"variance": 0.000603, "average": 0.99011, "min": 0.887113}, "location": {"width": 819, "top": 1182, "height": 60, "left": 263}, "words": "顺铂剂量调整的建议适用于与顺铂治疗有关的毒副作用而不是与卡培他滨或联合给药"}, {"probability": {"variance": 0.015728, "average": 0.965081, "min": 0.3977}, "location": {"width": 460, "top": 1242, "height": 35, "left": 222}, "words": "有关的毒副作用。铂剂量调整见顺铂说明书信息"}, {"probability": {"variance": 0.001444, "average": 0.990185, "min": 0.766265}, "location": {"width": 819, "top": 1279, "height": 38, "left": 223}, "words": "肾毒性:治疗前肌酐清除率应大于60 ml/min,同时应在每一疗程前根据 cockroft-gault公式"}, {"probability": {"variance": 0.00049, "average": 0.989793, "min": 0.915443}, "location": {"width": 508, "top": 1323, "height": 31, "left": 223}, "words": "计算出肌酐清除率第1个疗程后,如果肌酐清除率<60"}, {"probability": {"variance": 6e-06, "average": 0.998364, "min": 0.992581}, "location": {"width": 238, "top": 1320, "height": 27, "left": 803}, "words": "水化24小时后必须重新计"}, {"probability": {"variance": 0, "average": 0.991182, "min": 0.991182}, "location": {"width": 24, "top": 1368, "height": 25, "left": 225}, "words": "算"}, {"probability": {"variance": 0.006323, "average": 0.984201, "min": 0.541672}, "location": {"width": 664, "top": 1399, "height": 35, "left": 267}, "words": "肾功能受损的患者,顺铂剂量的调整必须与顺铂说明书信息中的指导一致"}, {"probability": {"variance": 0.000189, "average": 0.994468, "min": 0.932026}, "location": {"width": 540, "top": 1440, "height": 34, "left": 268}, "words": "在应用卡培他滨和顺铂的临床研究中,顺铂剂量调整见表7"}, {"probability": {"variance": 0.000682, "average": 0.989064, "min": 0.873749}, "location": {"width": 529, "top": 1478, "height": 34, "left": 372}, "words": "表7.顺铂和卡培他滨根据肌酐清除率进行的剂量调整方案"}, {"probability": {"variance": 0.002417, "average": 0.961587, "min": 0.849794}, "location": {"width": 187, "top": 1527, "height": 24, "left": 229}, "words": "肌酐清除率颛铂剂量"}, {"probability": {"variance": 0.005564, "average": 0.951459, "min": 0.788861}, "location": {"width": 106, "top": 1523, "height": 22, "left": 878}, "words": "卡培他滨剂建"}], "language": 3}